Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

Blood (2022) 139 (12): 1850–1862.

https://doi.org/10.1182/blood.2021011921

Published: 2022

Includes: Supplemental data

Journal Articles

Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

Blood (2021) 138 (Supplement 1): 2925.

https://doi.org/10.1182/blood-2021-147587

Published: 2021

Journal Articles

Sobuzoxane-Containing Regimens Show Promising Response As Salvage Therapy for Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS)

Ikuo Shimizu, MD, Wataru Takeda, MD, Takehiko Kirihara, MD, Keijiro Sato, MD, Yuko Fujikawa, MD, Toshimitsu Ueki, MD, Yuki Hiroshima, MD, PhD, Masahiko Sumi, MD, PhD, Mayumi Ueno, MD, PhD, Naoaki Ichikawa, MD, PhD, Hikaru Kobayashi, MD, PhD

Blood (2012) 120 (21): 4849.

https://doi.org/10.1182/blood.V120.21.4849.4849

Published: 2012

Journal Articles

Utility of Percutaneous Image-Guided Biopsy to Diagnose Intraabdominal Lymphoma with Coaxial Core Needles,

Ikuo Shimizu, MD, Keijiro Sato, MD, Yuko Fujikawa, MD, Toshimitsu Ueki, MD, Daigo Akahane, MD, PhD, Masahiko Sumi, MD, PhD, Mayumi Ueno, MD, PhD, Naoaki Ichikawa, MD, PhD, Hikaru Kobayashi, MD, PhD, Yoichi Okazaki, MD, PhD

Blood (2011) 118 (21): 4214.

https://doi.org/10.1182/blood.V118.21.4214.4214

Published: 2011

Journal Articles

Reduced-Intensity Cord Blood Transplantation without Preceding Remission Induction Therapy Induces Durable Remission in Patients with Relapsed Acute Leukemia After the First Allogeneic Stem Cell Transplantation.

Toshimitsu Ueki, MD, Kentaro Nasu, MD, Ikuo Shimizu, MD, Masahiko Sumi, MD, Mayumi Ueno, MD, Naoaki Ichikawa, MD, Hikaru Kobayashi, MD

Blood (2009) 114 (22): 4341.

https://doi.org/10.1182/blood.V114.22.4341.4341

Published: 2009

Journal Articles

Identification and Functional Significance of Genes Regulated by Structurally Different ABL Kinase Inhibitors.

Kousuke Nunoda, MD, Tetsuzo Tauchi, MD, Tomoiku Takaku, MD, Masahiko Sumi, MD, Seiichi Okabe, MD, Goro Sashida, MD, Daigo Akahane, MD, Junko H. Ohyashiki, MD, Kazuma Ohyashiki, MD

Blood (2005) 106 (11): 2860.

https://doi.org/10.1182/blood.V106.11.2860.2860

Published: 2005

Journal Articles

Activity of ABT-737, an Inhibitor of BCL-2 Family Proteins, in Imatinib- or Dasatinib-Resistant CML Cells: Involvement of BCL-2 Family Proteins for Drug Resistance.

Tetsuzo Tauchi, MD, Kousuke Nunoda, MD, Tomoiku Takaku, MD, Masahiko Sumi, MD, Daigo Akahane, MD, Goro Sashida, MD, Junko H. Ohyashiki, MD, Kazuma Ohyashiki, MD

Blood (2005) 106 (11): 3364.

https://doi.org/10.1182/blood.V106.11.3364.3364

Published: 2005

Journal Articles

Depsipeptide (FK228) Preferentially Induces Apoptosis in BCR/ABL-Expressing TF-1 Cells.

Seiichi Okabe, Tetsuzo Tauchi, Akihiro Nakajima, Goro Sashida, Masahiko Sumi, Akihiko Gotoh, Hal E. Broxmeyer, Junko H. Ohyashiki, Kazuma Ohyashiki

Blood (2005) 106 (11): 4845.

https://doi.org/10.1182/blood.V106.11.4845.4845

Published: 2005

Journal Articles

Specific Inhibition of hTERT by shRNA Sensitizes for Imatinib Mesylate in BCR-ABL-Positive Cells.

Goro Sashida, M.D., Tetsuzo Tauchi, M.D., Masahiko Sumi, M.D., Akihiro Nakajima, M.D., Junko H. Ohyashiki, M.D., Kazuma Ohyashiki, M.D.

Blood (2004) 104 (11): 4339.

https://doi.org/10.1182/blood.V104.11.4339.4339

Published: 2004

Journal Articles

Telomerase Inhibition with a Novel G-Quadruplex-Interactive Agent, Telomestatin: In Vitro and In Vivo Studies in Acute Leukemia.

Tetsuzo Tauchi, MD, Kazuo Shin-ya, PhD, Goro Sashida, MD, Masahiko Sumi, MD, Akihiro Nakajima, MD, Junko H. Ohyashiki, MD, Kazuma Ohyashiki, MD

Blood (2004) 104 (11): 3391.

https://doi.org/10.1182/blood.V104.11.3391.3391

Published: 2004

NARROW

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT

Sobuzoxane-Containing Regimens Show Promising Response As Salvage Therapy for Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS)

Utility of Percutaneous Image-Guided Biopsy to Diagnose Intraabdominal Lymphoma with Coaxial Core Needles,

Reduced-Intensity Cord Blood Transplantation without Preceding Remission Induction Therapy Induces Durable Remission in Patients with Relapsed Acute Leukemia After the First Allogeneic Stem Cell Transplantation.

Identification and Functional Significance of Genes Regulated by Structurally Different ABL Kinase Inhibitors.

Activity of ABT-737, an Inhibitor of BCL-2 Family Proteins, in Imatinib- or Dasatinib-Resistant CML Cells: Involvement of BCL-2 Family Proteins for Drug Resistance.

Depsipeptide (FK228) Preferentially Induces Apoptosis in BCR/ABL-Expressing TF-1 Cells.

Specific Inhibition of hTERT by shRNA Sensitizes for Imatinib Mesylate in BCR-ABL-Positive Cells.

Telomerase Inhibition with a Novel G-Quadruplex-Interactive Agent, Telomestatin: In Vitro and In Vivo Studies in Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only